Tan Xiaodong, Zhou Lei, Wang Wei, Wang Baosheng, Egami Hiroshi, Baba Hideo, Dai Xianwei
Department of Hepato-pancreato-biliary Tumor Surgery, China Medical University Shengjing Hospital, Shenyang, P.R. China ;
Exp Ther Med. 2010 Jan;1(1):211-216. doi: 10.3892/etm_00000034. Epub 2010 Jan 1.
Pancreatic cancer is known to be an extremely lethal neoplasm, one of the reasons being that pancreatic cancer itself has an extremely high potential of invasion-metastasis. In our previous study, two pancreatic cancer cell lines with a different potential for invasion-metastasis, PC-1 with a low potential and PC-1.0 with a high potential of invasion-metastasis after intrapancreatic transplantation, were established in a Syrian golden hamster. To determine the invasion-metastasis-related factors, a cDNA microarray that represented a set of 27,000 genes was hybridized with a labeled cDNA probe and screened for molecular profiling analysis. Furthermore, Gene Ontology and Pathway differential expression of candidate genes was further validated using RT-PCR. One hundred and forty-one differentially expressed genes (>3.0-fold change) were identified in the present study, including 46 up-regulated genes (e.g., nup107, tjp-2 and MMP-13) and 95 down-regulated genes (e.g., Spc21, plau and CD44) in the PC-1.0 cells. Our present results suggest that a highly organized and structured process of tumor invasion-metastasis exists in the pancreas. Analysis of gene expression profiles by cDNA microarray provides useful information for clarifying the mechanism underlying this invasion and metastasis. Furthermore, the identification of invasion-metastasis-specific genes may allow us to develop new therapeutic and diagnostic targets for the invasion-metastasis of pancreatic cancer.
胰腺癌是一种极具致死性的肿瘤,原因之一是胰腺癌本身具有极高的侵袭转移潜能。在我们之前的研究中,在叙利亚金黄地鼠体内建立了两种具有不同侵袭转移潜能的胰腺癌细胞系,胰腺内移植后侵袭转移潜能低的PC-1和侵袭转移潜能高的PC-1.0。为了确定侵袭转移相关因素,将代表27000个基因的cDNA微阵列与标记的cDNA探针杂交,并进行分子谱分析筛选。此外,使用逆转录聚合酶链反应进一步验证候选基因的基因本体论和通路差异表达。本研究共鉴定出141个差异表达基因(变化倍数>3.0),其中PC-1.0细胞中有46个上调基因(如nup107、tjp-2和MMP-13)和95个下调基因(如Spc21、plau和CD44)。我们目前的结果表明,胰腺中存在高度有组织和结构化的肿瘤侵袭转移过程。通过cDNA微阵列分析基因表达谱为阐明这种侵袭和转移的机制提供了有用的信息。此外,鉴定侵袭转移特异性基因可能使我们能够开发针对胰腺癌侵袭转移的新治疗和诊断靶点。